Results 291 to 300 of about 159,123 (340)
CD161 is identified as a novel inhibitory receptor on bone marrow (BM)‐resident CD8⁺ T cells in multiple myeloma (MM). Through interaction with its ligand CLEC2D, CD161 impairs T‐cell function and promotes immune suppression. Blockade of CD161 restores tissue residency and cytotoxicity of CD8⁺ T cells and enhances chimeric antigen receptor T‐cell (CAR ...
Liwen Wang +16 more
wiley +1 more source
Incidence, Risk Factors, and Subsequent Health Outcomes of Pyogenic Liver Abscesses: A Scoping Review of Evidence From Population-Based Studies. [PDF]
Wang S, Chang Z.
europepmc +1 more source
Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute's Cancer Information Service. [PDF]
Vanderpool RC +4 more
europepmc +1 more source
Burden of obesity in patients undergoing dialysis, and hopes associated with semaglutide treatment for transplant listing: An interview study. [PDF]
Vanek L +6 more
europepmc +1 more source

